Kindred Biosciences reported -8544000 in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Adma Biologics ADMA:US $ -14437080 1.14M
Bayer BAYN:GR 1.22B 426M
Biocryst Pharmaceuticals BCRX:US $ -44584000 15M
Eli Lilly And LLY:US $ 2055.2M 626.8M
Idexx Laboratories IDXX:US $ 225.96M 36.7M
JAZZ PHA JAZZ:US 28.37M 97.96M
Kindred Biosciences KIN:US -8544000 622K
Merk MRK:US $ 5352M 3083M
Minerva Neurosciences NERV:US $ -7517620 1.45M
Novavax NVAX:US $ -307144000 38.68M
Phibro Animal Health PAHC:US $ 14.61M 4.55M
Zoetis ZTS:US $ 735M 9M